Uncategorized Archives - Buhlmann Diagnostics Corp

Category: Uncategorized

Serum Calprotectin

BÜHLMAN sCAL turbo assay is for Research Use Only. Not for use in diagnostic procedures in the US. BÜHLMANN sCAL® turbo Serum Calprotectin (sCAL, aka: myeloid-related protein 8/14 (MRP8/14), S100A8/A9, calprotectin) is a powerful biomarker to study the inflammatory status of a subject whether it is a classical autoimmune mediated Rheumatoid Arthritis (RA) or a rare
Continue Reading

Buhlmann – Next Generation Food Allergy Drug Development Summit

Next Generation Food Allergy Drug Development Summit, July 20-22, 2021: BUHLMANN is proud to partner with this event, specifically focused on enhancing the food allergy drug development approach. Flow CAST® is the standardized, proven & assessable Basophil Activation Test. An accurate biomarker of an allergic reaction… in a vial. BUHLMANN Allergy Assay Offering Diagnosis of
Continue Reading

Digestive Disease Week 2021

Assays Offerings We offer the broadest fecal calprotectin (fCAL) product range in the industry, available in the United States, including FDA cleared and Research Use Only (RUO) kits. These fCAL related tests include FDA 510(k) cleared BÜHLMANN fCAL® ELISA, BÜHLMANN fCAL® turbo & CALEX® Cap; FDA exempt BÜHLMANN fPELA® turbo (Pancreatic Elastase); Tests available as
Continue Reading

Visit BUHLMANN at AACC 2021 (LIVE)

Assays Offerings Assays Offerings: BUHLMANN Diagnostic Corp (BDC), offers the broadest fecal calprotectin (fCAL) product range in the industry, available in the United States, including FDA cleared and Research Use Only (RUO) kits. These fCAL related tests include FDA 510(k) cleared BÜHLMANN fCAL® ELISA, BÜHLMANN fCAL® turbo & CALEX® Cap; FDA exempt BÜHLMANN fPELA® turbo
Continue Reading

Automate fecal Calprotectin and Pancreatic Elastase assay testing, with BÜHLMANN fCAL® turbo & fPELA® turbo US IVD application

BÜHLMANN fCAL® turbo or BÜHLMANN fPELA® turbo BÜHLMANN fCAL® turbo or BÜHLMANN fPELA® turbo currently have validated IVD application notes for use in the United States on the clinical chemistry analyzers listed below. These allow for the FDA 510(k) cleared fecal calprotectin or FDA Exempt fecal pancreatic elastase to be tested on the Roche cobas®
Continue Reading

BÜHLMANN anti-MAG autoantibodies ELISA Citations

US: BÜHLMANN GanglioCombi™ ELISA is for Research Use Only. Not for use in diagnostic procedures. Health Canada Licence: 100436 and 100476 The citation list should be used for information only. Van den Bergh, P.Y.K., et al., 2021: European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of
Continue Reading

BÜHLMANN anti-SGPG autoantibodies ELISA Citations

US: BÜHLMANN GanglioCombi™ ELISA is for Research Use Only. Not for use in diagnostic procedures. Health Canada Licence: 100436 and 100476 The citation list should be used for information only. Herrendorff R et , 2017: Selective in vivo removal of pathogenic anti-MAG autoantibodies, an antigen specific treatment option for anti-MAG neuropathy. PNAS, www.pnas.org/cgi/doi/10.1073/pnas.1619386114 DOI: 10.1073/pnas.1619386114
Continue Reading

BÜHLMANN anti Ganglioside antibodies Citations

US: BÜHLMANN GanglioCombi™ ELISA is for Research Use Only. Not for use in diagnostic procedures. Health Canada Licence: 100436 and 100476 The citation list should be used for information only. Toscano G et al., 2020; Guillain-Barré Syndrome Associated with SARS-CoV-2 (Letter to the editor); NEJM; April 27, 2020 DOI: 10.1056/NEJMc2009191 Continue Reading Delmont E et
Continue Reading

Protected: Historical Overview of Ganglioside Antibodies

There is no excerpt because this is a protected post.

Continue Reading

Neuroimmunology History

Page 1 of 3 1 2 3 »Sorry,You have not added any story yet References Chiba A et al. Latov N et al Ilyas, AA et al.
Continue Reading